Pharmaceutical Technology14h
FDA approves Azurity Pharmaceuticals’ Danziten for CML treatment
The US Food and Drug Administration (FDA) has approved Azurity Pharmaceuticals’ Danziten (nilotinib), the first and only ...
Pharmaceutical Technology15h
Bavarian Nordic shares sink by 12% after mpox sales slump in Q3
The Danish infectious disease specialist has $340m (DKK 2.4m) lined up through orders for its MVA-BN vaccine known under the ...
Pharmaceutical Technology13h
FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.
Pharmaceutical Technology21h
EMA’s CHMP recommends Sanofi’s Sarclisa approval for multiple myeloma
Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Sanofi’s Sarclisa combined with Velcade ...
Pharmaceutical Technology13h
AC Immune’s stock jumps after Parkinson’s therapy shows signs of benefit
AC Immune’s Phase II trial showed an increase in anti-a-syn antibodies following treatment with the Parkinson’s disease ...
Pharmaceutical Technology17h
Patient experience in the spotlight at Clinical Trials in Oncology Europe 2024
The two-day Oncology event will see industry experts from across the clinical trial space holding talks on subjects from AI ...
Pharmaceutical Technology19h
MSD secures worldwide license for LaNova’s LM-299
MSD has secured an exclusive worldwide license from LaNova Medicines for developing, manufacturing, and commercialising the ...
Pharmaceutical Technology19h
Trump picks vaccine sceptic RFK Jr to lead HHS in new administration
If confirmed as the HHS Secretary by the US Senate, RFK Jr will oversee federal agencies that dictate healthcare policy in ...
Pharmaceutical Technology5h
Merative MarketScan
The FDA has released final draft recommendations for using real-world data and evidence in drug development.